These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 349637

  • 1. [Oral contraceptives and thromboembolism (author's transl)].
    Sato K, Ogino M, Nakabayashi M, Sakamoto S.
    Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637
    [No Abstract] [Full Text] [Related]

  • 2. [Lipid metabolism disorders and increased vascular risk due to contraceptive steroids].
    Basdevant A, de Lignieres B, Mauvais-Jarvis P.
    Nouv Presse Med; 1976 Apr 23; 6(17):1469-72. PubMed ID: 1025526
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N, Porcelli A, Petrelli P, Amedeo M, Crivello T, Ferraris G.
    Minerva Ginecol; 1988 Sep 23; 40(9):559-62. PubMed ID: 2975773
    [No Abstract] [Full Text] [Related]

  • 4. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents].
    Gambini G, Farina G, Arbosti G.
    Med Lav; 1976 Sep 23; 67(2):152-7. PubMed ID: 1021708
    [No Abstract] [Full Text] [Related]

  • 5. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug 13; 92(665):98, 101. PubMed ID: 6933346
    [Abstract] [Full Text] [Related]

  • 6. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN, Slawson JG.
    J Fam Pract; 2001 Feb 13; 50(2):108. PubMed ID: 11219554
    [No Abstract] [Full Text] [Related]

  • 7. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C.
    Schweiz Rundsch Med Prax; 1979 Oct 09; 68(41):1321-9. PubMed ID: 394143
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Oral contraceptives: pharmacotherapy of normal women (author's transl)].
    Bühler FR.
    Schweiz Rundsch Med Prax; 1976 Jan 06; 65(1):3-5. PubMed ID: 1250821
    [Abstract] [Full Text] [Related]

  • 11. Letter: Prenatal sex-hormone exposure and congenital limb-reduction defects.
    Lancet; 1976 Aug 14; 2(7981):372-3. PubMed ID: 60606
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [In consideration of few mentioned aspects by application of hormonal contraceptives (author's transl)].
    Gitsch E.
    Ther Umsch; 1976 Apr 14; 33(4):218-21. PubMed ID: 1006576
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in the endometrium from the use of hormonal preparations and hormonal contraceptives].
    Jellinek G.
    Arkh Patol; 1978 Apr 14; 40(11):36-45. PubMed ID: 736819
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of hormonal contraceptives on cardiovascular function].
    Manuilova IA, Dubnitskaia LV, Trutko NS.
    Akush Ginekol (Mosk); 1983 Nov 14; (11):5-8. PubMed ID: 6364872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.